NCT05535270 is a clinical trial of Oxford Depression Questionnaire (ODQ) in Mood Disorders, sponsored by First Affiliated Hospital of Zhejiang University.

Who is sponsoring NCT05535270?

NCT05535270 is sponsored by First Affiliated Hospital of Zhejiang University.

What drugs are being tested in NCT05535270?

Interventions in NCT05535270: Oxford Depression Questionnaire (ODQ).

What condition does NCT05535270 study?

NCT05535270 studies Mood Disorders, Emotional Blunting.

Is NCT05535270 still recruiting?

NCT05535270 is currently completed. Last updated 15 September 2023.

Last reviewed 2023-09-15 · How we verify

NCT05535270

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of the Chinese Version of Oxford Depression Questionnaire

Completed Last updated 15 September 2023

What this trial tests

trial testing Oxford Depression Questionnaire (ODQ) in Mood Disorders in 272 participants. Completed in 30 June 2023.

Timeline

1 January 2022

Primary endpoint
1 June 2023

30 June 2023

Quick facts

Lead sponsor	First Affiliated Hospital of Zhejiang University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	272
Start date	1 January 2022
Primary completion	1 June 2023
Estimated completion	30 June 2023
Sites	1 location across China

Drugs / interventions tested

Oxford Depression Questionnaire (ODQ)

Conditions studied

Mood Disorders — all drugs for Mood Disorders →
Emotional Blunting — all drugs for Emotional Blunting →

Sponsor

First Affiliated Hospital of Zhejiang University

Who can join

Adults 13 to 65, any sex, with Mood Disorders or Emotional Blunting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Mood disorders are a group of psychiatric disorders that can affect a person's mood, energy, and motivation. Emotional blunting has been observed in clinical practice in patients with mood disorders. Emotional blunting has a negative impact on patients' overall treatment and leads to poorer adherence. The Oxford Depression Questionnaire (ODQ) is a measuring instrument of emotional blunting. The ODQ is expected to be a scientifically valid tool for detecting emotional blunting. The ODQ has high construct validity and internal reliability. However, no scientific validity studies have been conducted on ODQ in Chinese population. Therefore, this study is intended to investigate the reliability and validity of the ODQ in Chinese patients with mood disorders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mood Disorders

Currently open trials in the same condition.

NCT07523490 — Investigation on Suicide Risk Factors of Patients With Mood Disorders · recruiting
NCT07362511 — Imagery Rescripting in Primary Care · NA · recruiting
NCT07211750 — Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT · NA · recruiting
NCT07088939 — Feasibility and Acceptability of an E-learning Dialectical Behavior Therapy Skills Course · NA · recruiting
NCT06412315 — 7T Amygdala and Citalopram Study · NA · recruiting

Other First Affiliated Hospital of Zhejiang University trials

Trials by the same sponsor.

NCT07537192 — Inulin-Spirulina Co-intervention for Insomnia Disorder · NA · not yet recruiting
NCT07510867 — 18F-FAPI PET/CT and MRI in Gastric Cancer · not yet recruiting
NCT07589647 — Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic D · NA · recruiting
NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
NCT07468162 — Characteristic Electroencephalogram of General Anesthesia · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05535270 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Zhejiang University
Last refreshed: 15 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05535270.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing